These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 33577184)
1. Prevalence of masked hypertension evaluated by home blood pressure monitoring in a large sample of patients with office blood pressure <140/90 mmHg. Magalhães JA; Lins-Filho OL; de Couto TLG; Silva MVFP; Lustosa TC; Barroso WKS; Brandão AA; Miranda RD; Barbosa ECD; Gomes MAM; Nadruz W; Feitosa ADM; Pedrosa RP Blood Press Monit; 2021 Jun; 26(3):224-229. PubMed ID: 33577184 [TBL] [Abstract][Full Text] [Related]
2. Prevalence and Characteristics of Isolated Nighttime Masked Uncontrolled Hypertension in Treated Patients. Kim KH; Chung J; Jang S; Kim BK; Munakata M; Rhee MY Medicina (Kaunas); 2024 Sep; 60(9):. PubMed ID: 39336563 [No Abstract] [Full Text] [Related]
3. Prevalence of Masked and White-Coat Hypertension in Pre-Hypertensive and Stage 1 Hypertensive patients with the use of TeleMRPA. Barroso WKS; Feitosa ADM; Barbosa ECD; Miranda RD; Brandão AA; Vitorino PVO; Ribeiro LPS; Gomes MM Arq Bras Cardiol; 2019 Nov; 113(5):970-975. PubMed ID: 31432980 [TBL] [Abstract][Full Text] [Related]
4. The value of ambulatory blood pressure measurement to detect masked diastolic hypotension in older patients treated for hypertension. Kleipool EEF; Rozendaal ES; Mahadew SKN; Kramer MHH; van den Born BH; Serné EH; Peters MJL; Muller M Age Ageing; 2021 Jun; 50(4):1229-1235. PubMed ID: 33454734 [TBL] [Abstract][Full Text] [Related]
5. Blood Pressure Control in Hypertensive Patients, Cardiovascular Risk Profile and the Prevalence of Masked Uncontrolled Hypertension (MUCH). Naser N; Dzubur A; Durak A; Kulic M; Naser N Med Arch; 2016 Jul; 70(4):274-279. PubMed ID: 27703288 [TBL] [Abstract][Full Text] [Related]
6. Isolated uncontrolled hypertension at home and in the office among treated hypertensive patients from the J-HOME study. Obara T; Ohkubo T; Funahashi J; Kikuya M; Asayama K; Metoki H; Oikawa T; Hashimoto J; Totsune K; Imai Y J Hypertens; 2005 Sep; 23(9):1653-60. PubMed ID: 16093909 [TBL] [Abstract][Full Text] [Related]
7. Prevalence and determinants of masked hypertension among obese individuals at the Yaoundé Central Hospital: a cross-sectional study in sub-Saharan Africa. Hamadou B; Amougou SN; Tchuendem Y; Nganou-Gnindjio CN; Mfeukeu-Kuate L; Foka AJ; Tankeu AT; Jingi AM; Menanga AP; Kingue S Blood Press Monit; 2020 Aug; 25(4):212-215. PubMed ID: 32541260 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of prehypertension and masked hypertension rate among clinically normotensive patients. Unsal S; Ozkara A; Albayrak T; Ozturk Y; Beysel S; Kucukler FK Clin Exp Hypertens; 2016; 38(2):218-24. PubMed ID: 26818410 [TBL] [Abstract][Full Text] [Related]
9. [2013 Ambulatory blood pressure monitoring recommendations for the diagnosis of adult hypertension, assessment of cardiovascular and other hypertension-associated risk, and attainment of therapeutic goals (summary). Joint recommendations from the International Society for Chronobiology (ISC), American Association of Medical Chronobiology and Chronotherapeutics (AAMCC), Spanish Society of Applied Chronobiology, Chronotherapy, and Vascular Risk (SECAC), Spanish Society of Atherosclerosis (SEA), and Romanian Society of Internal Medicine (RSIM)]. Hermida RC; Smolensky MH; Ayala DE; Portaluppi F; Crespo JJ; Fabbian F; Haus E; Manfredini R; Mojón A; Moyá A; Piñeiro L; Ríos MT; Otero A; Balan H; Fernández JR Clin Investig Arterioscler; 2013; 25(2):74-82. PubMed ID: 23849214 [TBL] [Abstract][Full Text] [Related]
10. Accuracy of home versus ambulatory blood pressure monitoring in the diagnosis of white-coat and masked hypertension. Kang YY; Li Y; Huang QF; Song J; Shan XL; Dou Y; Xu XJ; Chen SH; Wang JG J Hypertens; 2015 Aug; 33(8):1580-7. PubMed ID: 26103131 [TBL] [Abstract][Full Text] [Related]
11. Impact of Asleep and 24-Hour Blood Pressure Data on the Prevalence of Masked Hypertension by Race/Ethnicity. Yano Y; Poudel B; Chen L; Sakhuja S; Jaeger BC; Viera AJ; Shimbo D; Clark D; Anstey DE; Lin FC; Lewis CE; Shikany JM; Rana JS; Correa A; Lloyd-Jones DM; Schwartz JE; Muntner P Am J Hypertens; 2022 Jul; 35(7):627-637. PubMed ID: 35303061 [TBL] [Abstract][Full Text] [Related]
12. Prognosis of white-coat and masked hypertension: International Database of HOme blood pressure in relation to Cardiovascular Outcome. Stergiou GS; Asayama K; Thijs L; Kollias A; Niiranen TJ; Hozawa A; Boggia J; Johansson JK; Ohkubo T; Tsuji I; Jula AM; Imai Y; Staessen JA; Hypertension; 2014 Apr; 63(4):675-82. PubMed ID: 24420553 [TBL] [Abstract][Full Text] [Related]
13. Prevalence and clinical characteristics of isolated-office and true resistant hypertension determined by ambulatory blood pressure monitoring. Ríos MT; Domínguez-Sardiña M; Ayala DE; Gomara S; Sineiro E; Pousa L; Callejas PA; Fontao MJ; Fernández JR; Hermida RC; Chronobiol Int; 2013 Mar; 30(1-2):207-20. PubMed ID: 23077975 [TBL] [Abstract][Full Text] [Related]
14. The impact of changing home blood pressure monitoring cutoff from 135/85 to 130/80 mmHg on hypertension phenotypes. Feitosa ADM; Mota-Gomes MA; Barroso WS; Miranda RD; Barbosa ECD; Brandão AA; Nobre F; Mion D; Amodeo C; Lima-Filho JL; Sposito AC; Nadruz W J Clin Hypertens (Greenwich); 2021 Jul; 23(7):1447-1451. PubMed ID: 33955645 [TBL] [Abstract][Full Text] [Related]
15. 2013 ambulatory blood pressure monitoring recommendations for the diagnosis of adult hypertension, assessment of cardiovascular and other hypertension-associated risk, and attainment of therapeutic goals. ; ; ; ; ; Hermida RC; Smolensky MH; Ayala DE; Portaluppi F Chronobiol Int; 2013 Apr; 30(3):355-410. PubMed ID: 23517220 [TBL] [Abstract][Full Text] [Related]
16. Blood pressure control in patients with chronic kidney disease according to office and home blood pressures. Chantrel F; Ott J; Dimitrov Y; Babici D; Fourcade J; Hanon O; Achard JM; Jabourek O; Ducher M; Fauvel JP; Blood Press Monit; 2020 Oct; 25(5):246-251. PubMed ID: 32842021 [TBL] [Abstract][Full Text] [Related]
17. A comparative meta-analysis of prospective observational studies on masked hypertension and masked uncontrolled hypertension defined by ambulatory and home blood pressure. Zhang DY; Guo QH; An DW; Li Y; Wang JG J Hypertens; 2019 Sep; 37(9):1775-1785. PubMed ID: 31219948 [TBL] [Abstract][Full Text] [Related]
18. Prevalence of masked uncontrolled and treated white-coat hypertension defined according to the average of morning and evening home blood pressure value: from the Japan Home versus Office Measurement Evaluation Study. Obara T; Ohkubo T; Kikuya M; Asayama K; Metoki H; Inoue R; Oikawa T; Komai R; Murai K; Horikawa T; Hashimoto J; Totsune K; Imai Y; Blood Press Monit; 2005 Dec; 10(6):311-6. PubMed ID: 16496446 [TBL] [Abstract][Full Text] [Related]
19. Determinants of masked hypertension in the general population: the Finn-Home study. Hänninen MR; Niiranen TJ; Puukka PJ; Mattila AK; Jula AM J Hypertens; 2011 Oct; 29(10):1880-8. PubMed ID: 21841499 [TBL] [Abstract][Full Text] [Related]
20. Association of Cardiovascular Outcomes With Masked Hypertension Defined by Home Blood Pressure Monitoring in a Japanese General Practice Population. Fujiwara T; Yano Y; Hoshide S; Kanegae H; Kario K JAMA Cardiol; 2018 Jul; 3(7):583-590. PubMed ID: 29800067 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]